Medicare Enrolled
Dr. Allen Hord, M.D.
Interventional Pain Medicine Physician · Atlanta, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Hord from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hord?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Hord
Dr. Allen Hord is an interventional pain medicine physician in Atlanta, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Hord performed 2,826 Medicare services across 1,363 unique beneficiaries.
Between the years covered by Open Payments, Dr. Hord received a total of $12,215 from 64 pharmaceutical and/or device companies across 343 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional pain medicine physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Hord is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 34% volume in GA
$12,215 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,826
Medicare services
Top 34% in GA for interventional pain medicine physician
1,363
Unique beneficiaries
$82
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~141 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
475 | $92 | $404 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
465 | $47 | $192 |
| Drug screening test A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample. |
320 | $60 | $193 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
308 | $67 | $281 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
182 | $189 | $618 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
150 | $107 | $612 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
76 | $111 | $355 |
| Additional sacral spine nerve root injection with imaging An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging. |
71 | $46 | $219 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
67 | $36 | $147 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint. |
60 | $55 | $308 |
| Injection of anesthetic or steroid into sacroiliac joint with imaging guidance This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection. |
50 | $77 | $415 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional upper or middle spinal facet joint. |
47 | $57 | $282 |
| Assessment of emotional or behavioral problems An evaluation to identify and understand emotional or behavioral issues. This process involves reviewing symptoms and behaviors to determine the nature of the concerns. |
47 | $4 | $14 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
43 | $185 | $1,232 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
43 | $63 | $221 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
42 | $153 | $470 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
41 | $103 | $691 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
41 | $135 | $630 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
39 | $59 | $401 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
37 | $40 | $256 |
| Psychological or neuropsychological test, first 30 minutes Administration of psychological or neuropsychological testing for the first 30 minutes. |
35 | $34 | $85 |
| Spinal injection with imaging guidance A procedure where medication is injected into the middle or upper part of the spinal canal. Imaging technology is used to guide the needle to the correct location. |
34 | $85 | $344 |
| Complex chronic care management, first 60 minutes This service involves clinical staff time directed by a healthcare professional to manage two or more chronic conditions over a calendar month. It covers the first 60 minutes of this coordinated care effort. |
29 | $107 | $401 |
| Facet joint nerve destruction, single joint This procedure uses imaging guidance to destroy the nerves supplying a single upper or middle spinal facet joint. It is performed to interrupt pain signals from that specific joint. |
27 | $165 | $965 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement. |
21 | $106 | $714 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
20 | $128 | $505 |
| Spinal nerve root injection with imaging guidance An injection of anesthetic or steroid medication into a single nerve root in the upper or middle spine. The procedure uses imaging guidance to ensure accurate placement. |
19 | $124 | $757 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
19 | $88 | $340 |
| Facet joint injection, second level, with imaging An injection into a second spinal facet joint in the upper or middle spine, guided by imaging to ensure accurate placement. |
18 | $61 | $422 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$12,215
Total received (2018-2024)
Avg $1,745/year across 7 years
Top 17% in GA for interventional pain medicine physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
64
Companies
343
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,215 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$936
2023
$693
2022
$1,557
2021
$1,357
2020
$1,547
2019
$1,848
2018
$4,276
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Forte Bio-Pharma LLC
$332
Stryker Corporation
$172
ABBVIE INC.
$104
Avanos Medical
$97
BIOTRONIK NRO, Inc.
$71
Boston Scientific Corporation
$63
ConvaTec Inc.
$24
Saluda Medical Americas, Inc.
$24
Amgen Inc.
$18
Fidia Pharma USA Inc.
$18
Collegium Pharmaceutical, Inc.
$15
Top 3 companies account for 64.9% of 2024 payments
All-time payments by company (2018-2024) ›
Nevro Corp.
$3,654
Medtronic USA, Inc.
$1,390
Abbott Laboratories
$1,102
Collegium Pharmaceutical, Inc.
$597
Boston Scientific Corporation
$577
Forte Bio-Pharma LLC
$488
Medtronic, Inc.
$314
Flexion Therapeutics, Inc.
$242
BIOTRONIK NRO, Inc.
$218
Stryker Corporation
$172
Bioventus LLC
$169
Amgen Inc.
$167
PFIZER INC.
$166
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$154
Daiichi Sankyo Inc.
$146
Egalet US Inc
$146
BioDelivery Sciences International, Inc.
$141
Sentynl Therapeutics, Inc.
$136
Relievant Medsystems, Inc.
$131
US WorldMeds, LLC
$125
Assertio Therapeutics, Inc.
$119
FORTE BIO-PHARMA LLC
$119
Trevena, Inc.
$105
ABBVIE INC.
$104
Stimwave Technologies Incorporated
$99
Avanos Medical
$97
Masimo Corporation
$94
TerSera Therapeutics LLC
$93
ARBOR PHARMACEUTICALS, INC.
$92
RedHill Biopharma Inc.
$74
Novartis Pharmaceuticals Corporation
$72
ASSERTIO THERAPEUTICS, Inc.
$71
AcelRx Pharmaceuticals, Inc.
$52
Zyla Life Sciences
$52
Horizon Therapeutics plc
$51
Tenex Health Inc.
$44
Pernix Therapeutics Holdings, Inc.
$41
Purdue Pharma L.P.
$37
Baudax Bio Inc.
$35
AstraZeneca Pharmaceuticals LP
$35
Almatica Pharma LLC
$33
Shionogi Inc
$32
ACACIA PHARMA INC
$32
Arbor Pharmaceuticals, Inc.
$30
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$29
Vertiflex, Inc.
$24
ConvaTec Inc.
$24
Saluda Medical Americas, Inc.
$24
Nalu Medical, Inc.
$23
Scilex Pharmaceuticals Inc.
$23
Nuvectra Corporation
$22
Pacira Pharmaceuticals Incorporated
$20
Flowonix Medical Incorporated
$18
Takeda Pharmaceuticals U.S.A., Inc.
$18
Fidia Pharma USA Inc.
$18
GRT US Holding, Inc.
$17
Kaleo, Inc.
$17
PROTEGA PHARMACEUTIALS LLC
$17
Vertical Pharmaceuticals, LLC
$15
INSYS Therapeutics Inc
$13
PROTEGA PHARMACEUTIALS INC
$13
Virtus Pharmaceuticals LLC
$12
Horizon Pharma plc
$12
Teva Pharmaceuticals USA, Inc.
$11
Top 3 companies account for 50.3% of all-time payments
Associated products mentioned in payments ›
AIMOVIG · AJOVY · ANJESO · AQUACEL AG+ EXTRA · ARYMO ER · Aimovig · Algovita · Amitiza · BELBUCA · BIOTRONIK · BOTOX · BUNAVAIL 2.1 mg 30-count box · BYFAVO · Cambia · DRG leads · DSUVIA · DUEXIS · Durolane · EVENITY · Evoke · Evzio · Exparel · FLECTOR · GELSYN 3 · GENERAL PAIN MANAGEMENT · GENERAL - PAIN MANAGEMENT · GENERATOR · GRALISE · General - Pain Management · Gralise · HYMOVIS · Horizant · INTELLIS · INTELLIS ADAPTIVESTIM · Intracept · LACTULOSE · LORZONE · LYRICA · Levorphanol · Levorphanol Tartrate · Lucemyra · Lucemyra/Lofexidine · MILD DEVICE KIT · MOVANTIK · MYSTIM · Morphabond ER · Movantik · NALOCET · Nalocet · Nalu Neurostimulation System · OLINVYK · Omnia · PENNSAID · PRIALT · PROCLAIM · PROLATE · Patient SafetyNet System · Proclaim Family of SCS IPGs · Proclaim IPG · Proclaim XR IPG · Prometra II · Prospera · Qutenza · RELISTOR · RELISTOR ORAL · RESTORE · ROXYBOND · Roxybond · SCS IPGs · SPECTRA WAVEWRITER · SPRIX · STANDARD RF DISPOSABLES · SUBSYS · SUPERION · SYMPROIC · Senza · Senza Spinal Cord Stimulation System · SlimTip lead DRG Lead · StimQ Receiver Stimulator Kit Channel A US w/Receiver · Superion ISS · Symproic · WaveWriter Alpha Prime 16 · XTAMPZA · XTAMPZAER · ZOHYDRO ER · ZORVOLEX · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zilretta · Zipsor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Interventional pain medicine physicians within 10 mi
32
Per 100K population
3.0
County median income
$91,490
Nearest hospital
SAINT JOSEPH'S HOSPITAL OF ATLANTA, INC
2.6 mi
2.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Hord is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 17% of GA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Hord experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Hord performed 475 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hord receive payments from pharmaceutical companies?
Yes. Dr. Hord received a total of $12,215 from 64 companies across 343 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hord's costs compare to other interventional pain medicine physicians in Atlanta?
Dr. Hord's average Medicare payment per service is $82. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hord) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Pain Medicine Physicians in Atlanta
Browse interventional pain medicine physicians in Atlanta ranked by procedure volume and transparency data.
Highest volume
Top Interventional Pain Medicine Physicians in GA
Interventional pain medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Pain Medicine Physicians in GA
Which GA interventional pain medicine physicians receive the most from drug and device companies.
By company
Nevro Corp. Payments to Doctors
See all physicians who received payments from Nevro Corp.
By company
Medtronic USA, Inc. Payments to Doctors
See all physicians who received payments from Medtronic USA, Inc.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology